Aiosyn

Curated by Signal

AI-based disease diagnosis tool for providers

Overview

AI-based disease diagnosis tool for providers. The company has developed software that assists with clinical disease diagnosis. It has features for breast and prostate cancer diagnostics, computational pathology, disease diagnosis, and more.

Key facts

Founded: 2021
Headquarters: Nijmegen, Netherlands
Stage: Sign up to view
Industry: Health Technology

Business model

4 products and services: Sign up to view
Commercial model: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

i45
Online platform helping employees integrate healthy habits into their daily routine through its Micro Habits program
Health TechnologyHelvoirt, Netherlands
Oxmed
Provider of ostomy products for for ostomates and healthcare professionals
Health TechnologyHeteren, Netherlands
Supplement Hub
Online retailer of nutritional supplements
Health TechnologyPurmerend, Netherlands

About Aiosyn

What does Aiosyn do?

AI-based disease diagnosis tool for providers.

Where is Aiosyn headquartered?

Aiosyn is headquartered in Nijmegen, Netherlands.

When was Aiosyn founded?

Aiosyn was founded in 2021.

Which sector is Aiosyn in?

Aiosyn operates in Health Technology.

Who are Aiosyn's competitors?

Companies similar to Aiosyn include i45, Oxmed, and Supplement Hub.